Northeast Tiger Pharmaceutical Co.
Northeast Tiger Pharmaceutical Co., Ltd. is principally engaged in the manufacturing and sale of Chinese medicine products in the People's Republic of China, as well as conducting pharmaceutical research and development. The Company sells its products under the brand name of Northeast Tiger. It operates primarily in People's Republic of China. The Company's main products include Lu Lu Tong Injection, Ling Yang Jiao Injection, Yong Chong cao Jun Powder Capsule, Shi Long Blood Clean Granules, Ling Yang Jiao Drop and Lu Lu Tong Xie Sha Tong Infusion Fluid.
See more information about Northeast Tiger Pharmaceutical Co.
Northeast Tiger Pharma posts 34pct hit to revenue, improves margins by 21pct
Northeast Tiger Pharmaceutical Co. posted a 34 percent drop in turnover year-on-year to RMB 20m, attributed to a drop of consumption caused by the financial crisis. Gross profit, however, increased 15.8 percent to RMB 9.7m thanks to the enhanced margins, which tightened by 21 percent as a result of the adjustment to the sales mix.
Operating expenses however rose 23 percent bringing pre-tax profit up 7 percent. The bottom line however dropped 70 percent to RMB 432,000 due to RMB1.2m of tax in deferred taxes.
Northeast Tiger Pharmaceuticals was located in Jilin City of Jilin Province, where traditional Chinese medicine resources are abundant. It produces and markets traditional Chinese medicine with the brand of "Northeast Tiger".
Shares of the company closed at HK$0.12 by the noon break, unchanged.
